Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 2 , Pages 141-146, March 2008

Androgen deprivation therapy for prostate cancer: Effects on hand function

  • Feray Soyupek, M.D.

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Suleyman Demirel University School of Medicine, Isparta, Turkey
  • ,
  • Sedat Soyupek, M.D.

      Affiliations

    • Department of Urology, Suleyman Demirel University School of Medicine, Isparta, Turkey
  • ,
  • Hakkı Perk, M.D.

      Affiliations

    • Department of Urology, Suleyman Demirel University School of Medicine, Isparta, Turkey
  • ,
  • Alper Özorak, M.D.

      Affiliations

    • Department of Urology, Suleyman Demirel University School of Medicine, Isparta, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-246-2112456; fax: +90-246-2371762.

Received 18 September 2006; received in revised form 13 December 2006; accepted 14 December 2006. published online 29 October 2007.

Abstract 

Objectives

Prostate cancer is the most frequently diagnosed malignancy. Luteinizing hormone-releasing hormone (LH-RH) agonists are used in most patients with locally advanced and metastatic prostate cancer, and decrease testosterone production. We aimed to find out the effects of androgen deprivation therapy with LH-RH agonist on the hand function, quality of life, and mood of the patients with prostate cancer.

Subjects

A total of 20 patients with locally advanced prostate cancer and 20 age-matched healthy men were included in the study as LH-RH and control groups, respectively.

Main Measures

Age, body mass index, occupation and dominant hand, physical activity level, Beck depression inventory scores, 15D quality of life questionnaire scores, and Duruoz hand index scores were recorded. Handgrip strength was tested in the dominant hand using the Jamar hand dynamometer (Sammons Preston, Inc., Bollingbrook, IL). The Grooved Pegboard Test was used to test manual dexterity. Serum concentrations of total and free testosterone, estradiol levels were measured.

Results

There were no differences between the groups in body mass index, physical activity level, and age (P > 0.05). Serum total and free testosterone, estradiol level, and the mean grip strength score were statistically lower in the LH-RH group. Manual dexterity was diminished in the LH-RH group (P < 0.001). The Duruoz hand index, and Beck depression inventory and 15D quality of life questionnaire scores were statistically lower in the LH-RH group (P < 0.005). We found a correlation between handgrip strength, dexterity, Beck depression inventory scores, 15D quality of life questionnaire scores, and total and free testosterone.

Conclusion

Men with low testosterone levels caused by androgen deprivation therapy have worse grip strength, dexterity, 15D quality of life questionnaire scores, and depressive symptoms than age-matched men who have not received androgen deprivation therapy.

Keywords: Androgen deprivation therapy, Depression, Dexterity, Hand, Quality of life, Testosterone

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(06)00323-1

doi:10.1016/j.urolonc.2006.12.014

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 2 , Pages 141-146, March 2008